Pharma

Jun 22, 2015 at 10:57 | Source: Moneycontrol.com
"The company had signed settlement agreement with few bond holders for settlement of the then outstanding 36,789 bonds of USD 1,000 each in principal value. Out of that 21,511 bonds have already been settled and cancelled," said the drug maker in its filing.
Jun 22, 2015 at 09:45 | Source: Moneycontrol.com
Shares of Lupin climbed nearly 2 percent in early trade Monday after it entered into 30-share BSE Sensex today. However, the Bombay Stock Exchange removed Tata Power from its benchmark.
Jun 22, 2015 at 09:11 | Source: Moneycontrol.com
List of top 10 buzzing stocks in the news today
Jun 21, 2015 at 14:57 | Source: PTI
Drugmaker Lupin will replace private sector electricity producer Tata Power on the BSE benchmark index Sensex from tomorrow.
Jun 19, 2015 at 14:18 | Source: CNBC-TV18
Speaking to CNBC-TV18 Surajit Pal, Pharma Analyst, Prabhudas Lilladher says that Glenmarks base rate would be lower than last year, as it receives Form 483 (observations) on recently inspected plants. Of the 45 new products 25-30 products will actualize by the next year.
Jun 19, 2015 at 14:00 | Source: Moneycontrol.com
M&M, Maruti Suzuki, HDFC, Vedanta, ONGC, Bank of Baroda and NMDC topped the buying list, up 2-5 percent. However, Tata Motors plunged 2.7 percent. Tata Power, GAIL, Sun Pharma, BHEL, Zee Entertainment and Power Grid Corp declined 1-2 percent.
Jun 19, 2015 at 13:10 | Source: Moneycontrol.com
"US Court of Appeals for Federal Circuit has again found Teva's US 808 patent for Copaxone to be invalid as indefinite. The company awaits approval from the US Food and Drug Administration (US FDA) to launch the product," said Natco in its filing to the exchange.
Jun 19, 2015 at 12:00 | Source: CNBC-TV18
Lalit Nambiar, senior VP & fund manager (equities) (HoR) at UTI mutual fund remains skeptical of a rebound in corporate earnings. Speaking to CNBC-TV18, he said the earnings will be flat for the next few quarters.
Jun 19, 2015 at 10:33 | Source: CNBC-TV18
Rajat Bose of rajatkbose.com is of the view that one may sell Glenmark Pharma.
Jun 19, 2015 at 09:19 | Source: CNBC-TV18
Deven Choksey of KR Choksey Shares & Securities is not sure whether the current rally is sustainable, but believes that the Nifty will remain rangebound between 8000 and 8400.
Messages on Pharma »

subs74

Silver Member

4 Followers

Biocon  

Namo baba, at the end of the day its about fundamentals as also whether stock is in strong hands. pls look at other midcap pharma stocks like cadila, zydus,ipca. They have all gone up even on such a day despite having run up already which means they are in strong hands who dont allow the stocks

4.54 PM Jul 8th 2014

abhishek_co
ssipore

New Member

1 Followers

Dishman Pharma  

Hold Dishman Pharma Targe Price 205

4.48 PM Jul 8th 2014

subs74

Silver Member

4 Followers

Biocon  

I can understand a minor correction due to market sentiment but a 7% fall in a pharma stock like Biocon on the day of railway budget with which it has no correlation is strange. Either the correction is silly or the upmove itself in Biocon was not based on any fundamentals.

4.33 PM Jul 8th 2014

Ajanta Pharma  

After AGM the share price will shoot up towards benefits to all investers - My target for Ajanta Pharma is Rs 2500 for the long term with a stoploss of Rs 1499

4.30 PM Jul 8th 2014

Ravi_jangra

New Member

0 Follower

Alembic Pharma  

Salute to alembic pharma....All stocks down but alembic not....Guys today see alembic strong unbreakable resistance on 300/-.This is righttime to entre now or never...Save me today from huge lose

4.19 PM Jul 8th 2014

jagoinvesto
r

Platinum Member

122 Followers

Morepen Lab  

morepen to buy sun pharma

4.15 PM Jul 8th 2014

JPInvestor

New Member

1 Followers

SMS Pharma  

my view is that the equity base of SMS Pharma is very small and already having good profit. hence it can easily cross the above figures.

3.55 PM Jul 8th 2014

subs74

Silver Member

4 Followers

Biocon  

How does budget affect pharma stocks like biocon?

3.47 PM Jul 8th 2014

shmarketgen
ius

Platinum Member

683 Followers

Tech Mahindra  

suggest,that you try & find a small/mid- cap Pharma/IT/Auto Ancillary company or a consumer play.These stories are huuuge in size & will pay rich dividends.

3.47 PM Jul 8th 2014

countryman

Platinum Member

855 Followers

Granules India  

For solving the problem of CAD, Re cannot go down so much to probably 53 levels which will hurt the exporters. I understand that RBI will control Re between 58 to 61 level so that exporters will get benefitted. Company has expanded their facilities, bought Auctus Pharma and this year Auctus

3.36 PM Jul 8th 2014

News across the web »
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.